Additional file 1 of Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis
posted on 2021-04-17, 03:20authored byVictoria S. Owen, Brianna K. Rosgen, Stephana J. Cherak, Andre Ferland, Henry T. Stelfox, Kirsten M. Fiest, Daniel J. Niven
Additional file 1. Table S1: MEDLINE search strategy. Table S2: Conference abstracts searched. Table S3: Demographic and clinical characteristics of patients who received peripheral intravenous vasopressors. Table S4: Adverse event characteristics. Table S5: Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). Table S6: JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data. Fig. S1: Funnel plot of studies included in the meta-analysis. Fig. S2: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of adult studies stratified by location of care. Fig. S3: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of Adult studies stratified by study design. Fig. S4: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of adult studies stratified by the mean/median duration of infusion. Fig. S5: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of adult studies stratified by Intravenous gauge. Fig. S6: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of Adult studies stratified by anatomical location. Fig. S7: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of adult studies stratified by vasopressor type. Fig. S8: Forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration of adult studies stratified by patient sex. Fig. S9: Sensitivity analysis of forest plot examining the incidence proportion of adverse events associated with peripheral intravenous vasopressor administration in adults.